We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

83 hedge funds and large institutions have $294M invested in VanEck Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

3.59% more ownership

Funds ownership: 41.64% → 45.23% (+3.6%)

2% more funds holding

Funds holding: 81 → 83 (+2)

12% less capital invested

Capital invested by funds: $333M → $294M (-$38.5M)

23% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 26

51% less call options, than puts

Call options by funds: $2.87M | Put options by funds: $5.85M

Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
26
Closed
11
Calls
$2.87M
Puts
$5.85M
Net Calls
-$2.98M
Net Calls Change
+$1.63M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$17.8M
2
VFAM
Valley Forge Asset Management
Pennsylvania
+$6.31M
3
Truist Financial
Truist Financial
North Carolina
+$4.84M
4
TRCT
Tower Research Capital (TRC)
New York
+$4.68M
5
CS
Credit Suisse
Switzerland
+$3.74M

Top Sellers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$7.44M
2
UCFA
United Capital Financial Advisors
Texas
-$7.28M
3
UBS Group
UBS Group
Switzerland
-$4.29M
4
ECML
Eagle Capital Management (Louisiana)
Louisiana
-$4.16M
5
Morgan Stanley
Morgan Stanley
New York
-$3.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
51
Signet Financial Management
New Jersey
$296K +$62.1K +469 +22%
PTC
52
Private Trust Company
Ohio
$287K – – –
NCM
53
Niemann Capital Management
Nevada
$285K -$506K -3,823 -61%
DBIA
54
Dumont & Blake Investment Advisors
New Jersey
$260K -$10.6K -80 -3%
SC
55
Scotia Capital
Ontario, Canada
$259K -$76.8K -580 -20%
CFMC
56
Curbstone Financial Management Corp
New Hampshire
$252K -$11.9K -90 -4%
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
$240K +$52.9K +400 +24%
Brown Advisory
58
Brown Advisory
Maryland
$223K +$258K +1,950 New
SIG
59
Stanford Investment Group
California
$191K – – –
SG Americas Securities
60
SG Americas Securities
New York
$185K -$872K -6,591 -80%
Envestnet Asset Management
61
Envestnet Asset Management
Illinois
$116K -$7.44M -56,213 -98%
CLOS
62
Compagnie Lombard Odier SCmA
Switzerland
$91K – – –
KCM
63
Karp Capital Management
California
$74K -$2.4M -18,160 -97%
WEC
64
Winslow Evans & Crocker
Massachusetts
$54.3K – – –
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$54K – – –
SHJ
66
Sharkey, Howes & Javer
Colorado
$46K – – –
BFEC
67
Benjamin F. Edwards & Company
Missouri
$43K – – –
KF
68
Krilogy Financial
Missouri
$43K +$50.3K +380 New
M
69
MOTCO
Texas
$34K – – –
KPCM
70
Kings Point Capital Management
New York
$31K – – –
AF
71
Arrow Financial
New York
$29K – – –
SJIM
72
St. Johns Investment Management
Florida
$17K – – –
US Bancorp
73
US Bancorp
Minnesota
$17K – – –
EDRE
74
Edmond de Rothschild (Europe)
Luxembourg
$15K – – –
AIP
75
Ameritas Investment Partners
Nebraska
$14K – – –
1 2
3
4

BBH Hedge Fund Activity: Q3 2015 in Review

83 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2015, worth a combined $294M — down 12% from $333M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 11 closed out — a net gain of 2 holders — while 20 added to existing stakes and 26 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $17.8M. The largest seller was Envestnet Asset Management, cutting an estimated $7.44M.

  • 83 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2015, up from 81 in Q2 2015.
  • Funds reported $294M of VanEck Biotech ETF stock for Q3 2015, down 12% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q3 2015 and 11 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2015 was Goldman Sachs, an estimated $17.8M added.
  • The largest VanEck Biotech ETF seller in Q3 2015 was Envestnet Asset Management, an estimated $7.44M sold.

Based on aggregated 13F filings for Q3 2015.